Oculis Holding AG (OCS) Depreciation & Amortization (CF) (2022 - 2024)
Oculis Holding AG (OCS) recorded quarterly Depreciation & Amortization (CF) of $33224.8 in Q1 2024, down 84.57% quarter-over-quarter from $215324.7 in Q4 2023, and down 12.2% on a YoY basis from $37840.7 in Q2 2023.
Oculis Holding AG (OCS) Depreciation & Amortization (CF) (2022 - 2024) Analysis & Trends
Oculis Holding AG's Depreciation & Amortization (CF) history runs 3 years deep, the most recent figure standing at $33224.8 for Q1 2024.
- In Q1 2024, Depreciation & Amortization (CF) fell 12.2% year-over-year to $33224.8; the TTM figure through Dec 2024 stood at $33224.8 (down 89.67% YoY), while the FY2025 annual figure was $683138.7, up 47.4% from the prior year.
- Depreciation & Amortization (CF) was $33224.8 for Q1 2024 at Oculis Holding AG, down from $215324.7 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $215324.7 in Q4 2023 to a low of $32832.4 in Q3 2023.
- Historically, Depreciation & Amortization (CF) has averaged $85078.7 across 3 years, with a median of $35589.6 in 2023.
- The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) advanced 3.72% in 2023, then declined 12.2% in 2024.
- A 3-year view of Depreciation & Amortization (CF) shows it stood at $207604.4 in 2022, then gained by 3.72% to $215324.7 in 2023, then sank by 84.57% to $33224.8 in 2024.
- The last three Depreciation & Amortization (CF) figures came in at $33224.8 (Q1 2024), $215324.7 (Q4 2023), and $32832.4 (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 429,663.65 |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 33,224.79 |
| Mar 31, 2024 | 33,224.79 |
| Dec 31, 2023 | 215,324.70 |
| Dec 31, 2023 | 215,324.70 |
| Sep 30, 2023 | 32,832.42 |
| Sep 30, 2023 | 32,832.42 |
| Jun 30, 2023 | 35,589.62 |
| Jun 30, 2023 | 35,589.62 |
| Mar 31, 2023 | 37,840.69 |
| Mar 31, 2023 | 37,840.69 |
| Dec 31, 2022 | 207,604.38 |
| Dec 31, 2022 | 207,604.38 |
| Sep 30, 2022 | 33,134.61 |
| Sep 30, 2022 | 33,134.61 |